Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review

2017 ◽  
Vol 86 ◽  
pp. 166-177 ◽  
Author(s):  
Lotte Keikes ◽  
Miriam Koopman ◽  
Pieter J. Tanis ◽  
Valery E.P.P. Lemmens ◽  
Cornelis J.A. Punt ◽  
...  
2017 ◽  
Vol 72 ◽  
pp. S53-S54
Author(s):  
L. Keikes ◽  
C. Punt ◽  
P. Tanis ◽  
M. Koopman ◽  
V. Lemmens ◽  
...  

BMJ Open ◽  
2013 ◽  
Vol 3 (7) ◽  
pp. e002818 ◽  
Author(s):  
Valentina Bianchi ◽  
Alessandra Spitale ◽  
Laura Ortelli ◽  
Luca Mazzucchelli ◽  
Andrea Bordoni ◽  
...  

Author(s):  
LA Henson ◽  
P Edmonds ◽  
H Johnson ◽  
A Johnston ◽  
CNY Ling ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Chloé Gervès-Pinquié ◽  
Anne Girault ◽  
Serena Phillips ◽  
Sarah Raskin ◽  
Mandi Pratt-Chapman

2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 234-234
Author(s):  
Santiago Fontes ◽  
Mauricio Cuello ◽  
Ana Marín-Jiménez ◽  
Juan Carlos Sánchez ◽  
Megan Berry ◽  
...  

234 Background: There is an urgent need to assess quality of cancer care in Latin America, especially amongst the most prevalent tumors, such as colorectal cancer. The main aim of this study was to assess adherence to previously validated quality indicators (QIs) for colorectal cancer in the context of a public healthcare provider in Uruguay. Methods: Data regarding all colorectal cancers registered between January 1, 2008 and December 31, 2019 at the National Cancer Institute of Montevideo was collected through retrospective analysis of medical records. We used 12 QIs (4 diagnostic, 7 treatment,1 surveillance) validated in previous publications. Each QI was analyzed as a proportion (%) and compared to target values with 95% confidence interval. Results: A total of 808 colorectal cancers were identified; only 10.1% were diagnosed by screening, 87% were diagnosed after reporting symptoms and 29.5% underwent emergency surgery. A complete preoperative colonoscopy was performed in 47% of patients, 64% had a CT-TAP scan and 63% of locally advanced rectal cancers had staging MRI prior to definitive treatment. Surgical resection with tumor free margins was obtained in 97% of cases, and for 68% at least 12 lymph nodes were examined. Neoadjuvant radiotherapy plus chemotherapy as first therapeutic strategy was implemented in 79% of rectal cancers. High risk stage II and III colon cancer received adjuvant chemotherapy within 16 weeks of surgery in 72,9% of cases. Postoperative follow up with CEA was registered in 97% of our series. Most patients ≤ 75 years of age with metastatic unresectable colorectal cancer at diagnosis underwent first-line chemotherapy or bio-chemotherapy. A low level of adherence was identified in micro-satellite and RAS status testing, 16 and 22 patients respectively. Conclusions: This study is a pioneer study in Latin America. The standardization of QI definition to achieve interregional comparative goals remains an unmet need.Our data indicates there is much to improve in early diagnosis, preoperative staging, neoadjuvant therapy and molecular testing. QI indicators in surgery and adjuvant chemotherapy prescription are similar to those reported in international studies.


2007 ◽  
Vol 0 (0) ◽  
pp. 070909172346001-??? ◽  
Author(s):  
Meenal Patwardhan ◽  
Deborah A. Fisher ◽  
Christopher R. Mantyh ◽  
Douglas C. McCrory ◽  
Michael A. Morse ◽  
...  

2013 ◽  
Vol 108 (7) ◽  
pp. 465-471 ◽  
Author(s):  
Gea A. Gooiker ◽  
Nikki E. Kolfschoten ◽  
Esther Bastiaannet ◽  
Cornelis J.H. van de Velde ◽  
Eric H. Eddes ◽  
...  

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e16509-e16509
Author(s):  
James Edward Ward ◽  
Keith Naylor ◽  
Blase N. Polite

e16509 Background: Disparities in colorectal cancer (CRC) outcomes among underrepresented racial and ethnic minority patients continue to widen. We performed, and present here, the results of a systematic review of the literature evaluating interventions to reduce racial and ethnic disparities in CRC care. Methods: The MEDLINE, PsycINFO, CINAHL, and Cochrane databases were searched for articles that focused on interventions to reduce disparities in CRC screening, treatment, survivorship and end-of-life care from 1950 to 2010. Studies included were those that evaluated interventions in US populations that were composed of ≥50% racial/ethnic minorities (or that included a specific sub-analysis by race/ethnicity). Results: Following the electronic search, abstract and full text review, and reference reviews; a total of thirty-three studies were included in our final analysis. All of these were related to CRC screening; no studies evaluating the rest of the cancer care continuum were found. Nineteen studies (58%) were randomized controlled trials, nine (27%) were pre-test/post-test analyses, and five (15%) were cohort studies. Thirteen studies (39%) targeted African-American populations, eight (24%) targeted Hispanics, two (6%) targeted Asian populations, seven (21%) included a mixed population of ethnic minorities, and three (9%) were listed as “non-white” or included a subgroup analysis. The main results related to the magnitude of the effect of these patient-directed, patient navigator, and provider-directed interventions on CRC screening is outlined in the table below. Conclusions: Patient education involving personal contact, patient navigation services, and provider-directed education and reminder systems can modestly improve adherence to CRC screening among minority patients. Further studies targeting the rest of the colon cancer care continuum are needed. [Table: see text]


2012 ◽  
Vol 38 (9) ◽  
pp. 790-791
Author(s):  
G. Gooiker ◽  
N.E. Kolfschoten ◽  
E. Bastiaannet ◽  
C.J.H. van de Velde ◽  
E.H. Eddes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document